26 July 2019 - Deborah Wilkes
Archived
Ipsen has reported results for the first half of 2019, Alliance Pharma has released a trading update, and Novartis intends to keep its Sandoz generics business.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.